Dr. David Dewitt Reynolds, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1860 Fair Ave., Suite A, Honesdale, PA 18431 Phone: 570-253-3391 Fax: 570-253-1811 |
Clifford Carrol, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 601 Park St, Honesdale, PA 18431 Phone: 570-253-8185 |
Dr. Matthew James Downey, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1860 Fair Avenue, Suite A, Honesdale, PA 18431 Phone: 570-253-3391 Fax: 570-253-1811 |
Leonard T Walsh, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1860 Fair Ave Ste A, Honesdale, PA 18431 Phone: 570-253-3391 Fax: 570-253-1811 |
Dr. James Donald Kutch, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1860 Fair Ave, Suite A, Honesdale, PA 18431 Phone: 570-253-3391 Fax: 570-253-1811 |
Dr. David A Talenti, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1860 Fair Ave, Suite A, Honesdale, PA 18431 Phone: 570-253-3391 |
News Archive
Samuel Young, Jr., PhD at the Max Planck Florida Institute for Neuroscience has been awarded a $2.4 million, five-year grant from the National Institute on Deafness and Other Communication Disorders to investigate how synaptic vesicle activity modulates the transfer of auditory information and ultimately how this impacts our ability to discern sounds.
To reduce the number of discards and thus make more kidneys available, researchers and medical scientists from the European consortium MABSOT have created a new drug called OPN-305 to reduce inflammation of the donor organ after transplantation.
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced a new application process for its major block grant programs - the Substance Abuse Prevention and Treatment Block Grant and the Community Mental Health Services Block Grant. The change is designed to provide states greater flexibility to allocate resources for substance abuse and mental illness prevention, treatment and recovery services in their communities.
Continuing medical education, newsletters and resource guides were only partially successful in changing the way that pediatricians handled behavioral health problems, according to a follow-up study at Wake Forest University School of Medicine.
Elusys Therapeutics, Inc. (Elusys), a privately-held biopharmaceutical company, announced today that it has signed a contract potentially totaling up to $143 million to complete the final development, commercial manufacturing and licensure of Anthim, the company's late stage anthrax therapeutic.
› Verified 6 days ago